COMMUNIQUÉS West-GlobeNewswire

CURE Pharmaceutical Appoints Chairman, Adds Member to its Board of Directors

15/01/2019 - 13:25

The revolutionary drug delivery leader taps global finance strategist, William (Bill) Yuan, to head growing Board, which now includes prominent biotech investor, Dr. Gene Salkind OXNARD, Calif., Jan. 15, 2019 (GLOBE [...]

Sol-Gel Technologies Appoints John Vieira as U.S. Head of Commercialization

15/01/2019 - 13:05

NESS ZIONA, Israel, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer

15/01/2019 - 13:03

CAMBRIDGE, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]

Emerald Health Therapeutics Announces Secondary Offering

15/01/2019 - 13:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (“Emerald” or [...]

CampDoc Partners with Oliver’s Labels to Develop Exclusive Safety Package for Camps

15/01/2019 - 11:30

ANN ARBOR, Mich., Jan. 15, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps, and Oliver’s Labels, a leading provider of durable personalized labels and tags for kids, have [...]

Transactions in relation to share buyback program

15/01/2019 - 11:22

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Time for Your Best Self in 2019 with the Y-Lift® and J-Plasma Combo Treatment

15/01/2019 - 11:00

MELBOURNE, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Dermatology + Plastic Surgery is on the forefront of anti-aging aesthetic care by combining two board certified physicians and two innovative techniques – Y-Lift® and [...]

ALK's Board of Directors to nominate Vincent Warnery as new member of the Board

15/01/2019 - 09:58

The Board of Directors of ALK-Abelló A/S ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) is pleased to announce that it will nominate Vincent Warnery as an independent member of the Board of ALK-Abelló A/S at the Annual [...]

European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea® product information

15/01/2019 - 08:30

Efficacy data from sub-group analysis for Apealea show significant advantage with regards to progression free survival in patients with first relapse. Oasmia Pharmaceutical AB (NASDAQ: OASM) AB today announce that the [...]

AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA

15/01/2019 - 08:00

AroCell AB (publ) announced today that a distribution agreement has been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210™ ELISA in China. The pharmaceutical and [...]

Achim von Leoprechting promoted to become CEO of Tecan after retirement of David Martyr

15/01/2019 - 07:21

Männedorf, Switzerland, January 15, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) announced today the retirement of Tecan CEO Dr David Martyr after 6 1/2 years at the helm of the company. The Board of Directors has [...]

Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock

15/01/2019 - 04:23

HOUSTON, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio [...]

ASLAN Pharmaceuticals to Present Positive varlitinib Data in First-Line Biliary Tract Cancer in Combination With Chemotherapy at ASCO GI

14/01/2019 - 23:44

Objective Response Rate of 60% and Disease Control Rate of 100% observed in 300mg dose cohort Data demonstrate increased activity of varlitinib in combination with gem/cis compared to standard of care SINGAPORE, Jan. 15 [...]

Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock

14/01/2019 - 23:29

RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

14/01/2019 - 22:35

NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) , a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]

CFN Media to Film Interviews at the Benzinga Cannabis Capital Conference

14/01/2019 - 22:33

Seattle, Washington, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”) , the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]

BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma

14/01/2019 - 22:15

CAMBRIDGE, Mass. and BEIJING, China, Jan. 14, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results

14/01/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report fourth quarter and full [...]

HTG Molecular Announces Executive Transition Plan

14/01/2019 - 22:05

Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019 John Lubniewski, President and Chief Operating Officer, appointed as successor TUCSON, Ariz., Jan. 14, 2019 (GLOBE [...]